Logotype for Nippon Chemical Industrial Co Ltd

Nippon Chemical Industrial (4092) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Nippon Chemical Industrial Co Ltd

Q1 2026 earnings summary

14 Apr, 2026

Executive summary

  • Net sales rose 5.5% year-over-year in the first quarter to ¥10,949 million, driven by higher volumes in both inorganic and specialty chemicals, but operating profit declined 34.2% to ¥1,110 million due to higher costs and production facility consolidation.

  • Ordinary profit decreased 34.9% year-over-year to ¥1,134 million, and profit attributable to owners of parent fell 3.9% to ¥1,203 million.

  • Comprehensive income dropped 41.4% year-over-year to ¥1,005 million.

  • Compared to initial forecasts, both net sales and operating profit exceeded expectations, supported by strong demand for electronic ceramic materials and cost reductions.

  • A gain on sale of non-current assets was recorded from land sales by a subsidiary.

Financial highlights

  • First quarter net sales: ¥10,949 million (+5.5% YoY); operating profit: ¥1,110 million (−34.2% YoY); ordinary profit: ¥1,134 million (−34.9% YoY); net profit: ¥1,203 million (−3.9% YoY).

  • EBITDA for the quarter was ¥2,062 million, down 21.4% year-over-year.

  • Basic earnings per share for the quarter: ¥137.74, down from ¥141.94 in the prior year.

  • Gross profit decreased from ¥3,047 million to ¥2,404 million year-over-year, while cost of sales increased from ¥7,331 million to ¥8,545 million.

  • Total assets increased to ¥76,214 million as of June 30, 2025, up from ¥75,105 million at the previous fiscal year-end.

Outlook and guidance

  • Full-year net sales forecast revised upward to ¥40.5 billion (+3.8% vs. previous forecast, up 4.3% YoY); operating profit forecast raised to ¥3.2 billion (+128.6% vs. previous forecast, projected to decline 4.3% YoY).

  • Net profit forecast for the year increased to ¥2.6 billion (+136.4% vs. previous forecast, up 1.6% YoY).

  • Assumed exchange rate revised from ¥158/$ to ¥145/$, reducing raw material procurement costs.

  • Annual dividend forecast raised to ¥120 per share, up ¥28 year-over-year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more